Background The purpose of this study was to investigate the effects of sub-chronic high fat,
high sucrose diet (also termed 'Westernized diet'or WD) feeding on the liver transcriptome …

Nonalcoholic steatohepatitis (NASH) can progress into liver cirrhosis; however, no definite
treatment is available. Omega-3 polyunsaturated fatty acid (omega-3) has been reported to …

Non-alcoholic steatohepatitis (NASH) is a fast-growing liver disorder that is associated with
an increased incidence of cardiovascular disease and type 2 diabetes. Animal models …

Background and aim Non-alcoholic fatty liver disease (NAFLD) is becoming a leading cause
of chronic liver disease worldwide. The molecular events that influence disease progression …

The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased in parallel with
central obesity and is now the most common chronic liver disease in developed countries …

Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic seatohepatitis (NASH) is one of
the major health problems world wide, because of increased abdominal obesity. To date …

Background Obesity and diabetes are frequently associated with nonalcoholic
steatohepatitis (NASH), but studies have been hampered by the absence of a suitable …

Lipotoxicity is a key player in the pathogenesis of nonalcoholic steatohepatitis (NASH), a
progressive subtype of nonalcoholic fatty liver disease (NAFLD). In the present study, we …

Nonalcoholic fatty liver disease (NAFLD) encompasses nonalcoholic steatohepatitis (NASH)
and affects 25% of the global population. Although a plethora of experimental models for …

Nonalcoholic steatohepatitis (NASH) is a chronic liver disease closely associated with
obesity, type 2 diabetes and hyperlipidemia. For further understanding of NASH …